Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis

Klaus Brasso; Frederik Birkebæk Thomsen; Martin Andreas Røder; AJ Schrader; SC Schmid; D Lorente; M Retz; AS Merseburger; CA von Klot; M Boegemann; Johann de Bono

doi:10.1016/S0090-4295(14)01020-6

Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis

Klaus Brasso, Frederik Birkebæk Thomsen, Martin Andreas Røder, AJ Schrader, SC Schmid, D Lorente, M Retz, AS Merseburger, CA von Klot, M Boegemann, Johann de Bono

Original language	English
Article number	UP697
Journal	Urology
Volume	84
Issue number	4
Pages (from-to)	S171-S387
ISSN	0090-4295
DOIs	https://doi.org/10.1016/S0090-4295(14)01020-6
Publication status	Published - 2014

Access to Document

10.1016/S0090-4295(14)01020-6

http://www.goldjournal.net/article/S0090-4295(14)01020-6/abstract

Cite this

Brasso, K., Thomsen, F. B., Røder, M. A., Schrader, AJ., Schmid, SC., Lorente, D., Retz, M., Merseburger, AS., von Klot, CA., Boegemann, M., & de Bono, J. (2014). Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis. Urology, 84(4), S171-S387. Article UP697. https://doi.org/10.1016/S0090-4295(14)01020-6

Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis. / Brasso, Klaus; Thomsen, Frederik Birkebæk; Røder, Martin Andreas et al.
In: Urology, Vol. 84, No. 4, UP697, 2014, p. S171-S387.

Research output: Contribution to journal › Conference abstract in journal › Research

Brasso, K, Thomsen, FB, Røder, MA, Schrader, AJ, Schmid, SC, Lorente, D, Retz, M, Merseburger, AS, von Klot, CA, Boegemann, M & de Bono, J 2014, 'Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis', Urology, vol. 84, no. 4, UP697, pp. S171-S387. https://doi.org/10.1016/S0090-4295(14)01020-6

@article{af4affb21c724f4baacef17d38d49553,

title = "Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis",

author = "Klaus Brasso and Thomsen, {Frederik Birkeb{\ae}k} and R{\o}der, {Martin Andreas} and AJ Schrader and SC Schmid and D Lorente and M Retz and AS Merseburger and {von Klot}, CA and M Boegemann and {de Bono}, Johann",

year = "2014",

doi = "10.1016/S0090-4295(14)01020-6",

language = "English",

volume = "84",

pages = "S171--S387",

journal = "Urology",

issn = "0090-4295",

publisher = "Excerpta Medica, Inc",

number = "4",

}

TY - ABST

T1 - Enzalutamide in patients with metastatic castration resistant prostate cancer previously managed with docetaxel and abiraterone: a multicenter analysis

AU - Brasso, Klaus

AU - Thomsen, Frederik Birkebæk

AU - Røder, Martin Andreas

AU - Schrader, AJ

AU - Schmid, SC

AU - Lorente, D

AU - Retz, M

AU - Merseburger, AS

AU - von Klot, CA

AU - Boegemann, M

AU - de Bono, Johann

PY - 2014

Y1 - 2014

U2 - 10.1016/S0090-4295(14)01020-6

DO - 10.1016/S0090-4295(14)01020-6

M3 - Conference abstract in journal

SN - 0090-4295

VL - 84

SP - S171-S387

JO - Urology

JF - Urology

IS - 4

M1 - UP697

ER -